TY - JOUR
T1 - Paroxysmal Atrial Fibrillation in Cryptogenic Stroke Patients With Major-Vessel Occlusion
AU - Doijiri, Ryosuke
AU - Yamagami, Hiroshi
AU - Morimoto, Masafumi
AU - Iwata, Tomonori
AU - Hashimoto, Tetsuya
AU - Sonoda, Kazutaka
AU - Yamazaki, Hidekazu
AU - Koge, Junpei
AU - Kimura, Naoto
AU - Todo, Kenichi
N1 - Publisher Copyright:
© Copyright © 2020 Doijiri, Yamagami, Morimoto, Iwata, Hashimoto, Sonoda, Yamazaki, Koge, Kimura and Todo.
PY - 2020/11/12
Y1 - 2020/11/12
N2 - Background and Purpose: To determine whether acute major-vessel occlusion (MVO) predicts atrial fibrillation (AF) in cryptogenic stroke (CS) patients, we analyzed the association between acute MVO and AF detected by insertable cardiac monitoring (ICM). Methods: We conducted a retrospective, multicenter, observational study of patients with CS who underwent ICM implantation between October 2016 and March 2018. In this analysis, we included follow-up data until June 2018. We analyzed the association of MVO with AF detected by ICM. Results: We included 84 consecutive patients with CS who underwent ICM implantation. The proportion of patients with newly detected AF by ICM was higher in patients with MVO than in those without (41% [12/29] vs. 13% [7/55], p < 0.01) within 90 days of ICM implantation. The MVO was associated with AF after adjustment for each clinically relevant factor. Conclusions: MVO was independently associated with AF detection in patients with CS, which suggests that MVO may be a useful predictor of latent AF. It is therefore essential to actively assess latent AF in patients with CS presenting with MVO.
AB - Background and Purpose: To determine whether acute major-vessel occlusion (MVO) predicts atrial fibrillation (AF) in cryptogenic stroke (CS) patients, we analyzed the association between acute MVO and AF detected by insertable cardiac monitoring (ICM). Methods: We conducted a retrospective, multicenter, observational study of patients with CS who underwent ICM implantation between October 2016 and March 2018. In this analysis, we included follow-up data until June 2018. We analyzed the association of MVO with AF detected by ICM. Results: We included 84 consecutive patients with CS who underwent ICM implantation. The proportion of patients with newly detected AF by ICM was higher in patients with MVO than in those without (41% [12/29] vs. 13% [7/55], p < 0.01) within 90 days of ICM implantation. The MVO was associated with AF after adjustment for each clinically relevant factor. Conclusions: MVO was independently associated with AF detection in patients with CS, which suggests that MVO may be a useful predictor of latent AF. It is therefore essential to actively assess latent AF in patients with CS presenting with MVO.
UR - http://www.scopus.com/inward/record.url?scp=85096781486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096781486&partnerID=8YFLogxK
U2 - 10.3389/fneur.2020.580572
DO - 10.3389/fneur.2020.580572
M3 - Article
AN - SCOPUS:85096781486
SN - 1664-2295
VL - 11
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 580572
ER -